Translational development of an SGLT2-targeted near-infrared contrast agent for intraoperative imaging of early-stage lung cancer
{{output}}
Background: Non-small cell lung cancer (NSCLC) is increasingly diagnosed at early stages, yet intraoperative localization of small and subsolid lesions remains challenging. Intraoperative molecular imaging (IMI) using tumor-targe... ...
